174 related articles for article (PubMed ID: 33826962)
1. Controlling the selectivity of aminergic GPCR ligands from the extracellular vestibule.
Egyed A; Kelemen ÁA; Vass M; Visegrády A; Thee SA; Wang Z; de Graaf C; Brea J; Loza MI; Leurs R; Keserű GM
Bioorg Chem; 2021 Jun; 111():104832. PubMed ID: 33826962
[TBL] [Abstract][Full Text] [Related]
2. The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.
Egyed A; Kiss DJ; Keserű GM
Front Pharmacol; 2022; 13():847788. PubMed ID: 35355719
[TBL] [Abstract][Full Text] [Related]
3. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
Fronik P; Gaiser BI; Sejer Pedersen D
J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
[TBL] [Abstract][Full Text] [Related]
4. Structure of the dopamine D3 receptor bound to a bitopic agonist reveals a new specificity site in an expanded allosteric pocket.
Arroyo-Urea S; Nazarova AL; Carrión-Antolí Á; Bonifazi A; Battiti FO; Lam JH; Newman AH; Katritch V; García-Nafría J
Res Sq; 2023 Dec; ():. PubMed ID: 38196573
[TBL] [Abstract][Full Text] [Related]
5. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
[TBL] [Abstract][Full Text] [Related]
7. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
Feng Z; Hu G; Ma S; Xie XQ
AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
[TBL] [Abstract][Full Text] [Related]
8. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
Valant C; Sexton PM; Christopoulos A
Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
[TBL] [Abstract][Full Text] [Related]
9. Bridging the gap: bitopic ligands of G-protein-coupled receptors.
Lane JR; Sexton PM; Christopoulos A
Trends Pharmacol Sci; 2013 Jan; 34(1):59-66. PubMed ID: 23177916
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands.
Gado F; Ferrisi R; Polini B; Mohamed KA; Ricardi C; Lucarini E; Carpi S; Domenichini F; Stevenson LA; Rapposelli S; Saccomanni G; Nieri P; Ortore G; Pertwee RG; Ghelardini C; Di Cesare Mannelli L; Chiellini G; Laprairie RB; Manera C
J Med Chem; 2022 Jul; 65(14):9918-9938. PubMed ID: 35849804
[TBL] [Abstract][Full Text] [Related]
13. Controlling receptor function from the extracellular vestibule of G-protein coupled receptors.
Egyed A; Domány-Kovács K; Koványi B; Horti F; Kurkó D; Kiss DJ; Pándy-Szekeres G; Greiner I; Keserű GM
Chem Commun (Camb); 2020 Nov; 56(91):14167-14170. PubMed ID: 33079104
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptor.
Keov P; López L; Devine SM; Valant C; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
J Biol Chem; 2014 Aug; 289(34):23817-37. PubMed ID: 25006252
[TBL] [Abstract][Full Text] [Related]
15. Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation.
Matera C; Kauk M; Cirillo D; Maspero M; Papotto C; Volpato D; Holzgrabe U; De Amici M; Hoffmann C; Dallanoce C
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903650
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
Keov P; Sexton PM; Christopoulos A
Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
[TBL] [Abstract][Full Text] [Related]
18. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
[TBL] [Abstract][Full Text] [Related]
19. The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors.
Volpato D; Kauk M; Messerer R; Bermudez M; Wolber G; Bock A; Hoffmann C; Holzgrabe U
ACS Omega; 2020 Dec; 5(49):31706-31715. PubMed ID: 33344823
[TBL] [Abstract][Full Text] [Related]
20. Novel Allosteric Modulators of G Protein-coupled Receptors.
Gentry PR; Sexton PM; Christopoulos A
J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
